Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock

INTRODUCTION: Cardiogenic shock refractory to standard therapy with inotropes and/or intra-aortic balloon pump is accompanied with an unacceptable high mortality. Percutaneous left ventricular assist devices may provide a survival benefit for these very sick patients. In this study, we describe our...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaudard, Philippe, Mourad, Marc, Eliet, Jacob, Zeroual, Norddine, Culas, Geraldine, Rouvière, Philippe, Albat, Bernard, Colson, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600310/
https://www.ncbi.nlm.nih.gov/pubmed/26453047
http://dx.doi.org/10.1186/s13054-015-1073-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600310/
https://www.ncbi.nlm.nih.gov/pubmed/26453047
http://dx.doi.org/10.1186/s13054-015-1073-8

Ejemplares similares